Table 1 Characteristics of participants of the main exposure sample. Continuous variables are reported as mean (SD) and categorical variables as absolute frequency (percentage)
Variable | Total N = 360 |
|---|---|
Age (years) | 56.3 (9.2) |
Female sex | 151 (41.9%) |
BMI (kg/m2) | 28.0 (4.8) |
Regularly physically active | 215 (59.7%) |
Smoking status | Â |
 Currently smoking | 72 (20%) |
 Ex - Smoker | 156 (43.3%) |
 Never - Smoker | 132 (36.7%) |
Alcohol consumption (g/day) | 18.3 (24.0) |
Diabetes status (based on OGTT) | Â |
 Normoglycemic | 221 (61.4%) |
 Prediabetes | 97 (26.9%) |
 Type 2 diabetes | 42 (11.7%) |
Fasting glucose (mg/dl) | 103.8 (22.6) |
Hypertension | 115 (32.0%) |
Systolic blood pressure (mmHg) | 120.3 (16.7) |
Diastolic blood pressure (mmHg) | 75.4 (10.0) |
Angina pectoris | 23 (6.4%) |
Total cholesterol (mg/dl) | 217.68 (36.4) |
HDL cholesterol (mg/dl) | 61.59 (17.1) |
LDL cholesterol (mg/dl) | 139.8 (32.9) |
Triglycerides (mg/dl) | 130.7 (85.2) |
hsCRP (mg/L) * | 1.15 (0.6; 2.5) |
Antidiabetic drugs | 24 (6.7%) |
Antihypertensive drugs | 84 (23.3%) |
Lipid lowering drugs | 37 (10.3%) |
Anticoagulant drugs | 6 (1.7%) |
Antiplatelet drugs | 13 (3.6%) |
SCORE2, % | 5.2 (3.8) |